Episode 440: An MS Specialist's Response to the FDA with Dr. William Conte

Episode 440: An MS Specialist's Response to the FDA with Dr. William Conte

This past December, the FDA issued a Complete Response Letter to drug manufacturer Sanofi in response to Sanofi's application seeking approval for Tolebrutinib, the first in a new category of investigational disease-modifying therapies to undergo FDA review. A Complete Response Letter is an official letter from the FDA to a drug manufacturer stating that the agency can't approve a new medicine in its current form. It's not an outright "no" that kills a project; it's more like a "not yet." However, this Complete Response Letter raised some issues which, at first glance, don't appear to be easily fixable.

Sanofi has pointed out that the issues raised in the Complete Response Letter were markedly different from the guidance they received from the FDA over the course of this approval process. Sanofi has also indicated that it would work with the FDA to find a path forward for Tolebrutinib.

Dr. William Conte, an MS Specialist and a principal investigator in the Phase 3 clinical trial for Tolebrutinib, has published an article responding to the FDA's Complete Response Letter. This week, Dr. Conte joins me to discuss the FDA's action and his response to that action.

We have a lot to talk about! Are you ready for RealTalk MS??!

This Week: We're at the 2026 ACTRIMS Forum :22

Check out the official ACTRIMS Forum Insider podcast! :42

The FDA's Complete Response Letter about Tolebrutinib 1:09

Dr. William Conte responds to the FDA's Complete Response Letter 4:09

Share this episode 38:10

Next week's episode 38:30

SHARE THIS EPISODE OF REALTALK MS

Just copy this link & paste it into your text or email: https://realtalkms.com/440

ADD YOUR VOICE TO THE CONVERSATION

I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!

Email: jon@realtalkms.com
Phone: (310) 526-2283

And don't forget to join us in the RealTalk MS Facebook group!

LINKS

If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com

Support Jon at WALK MS
https://realtalkms.com/walkms

Find out about ABLEnow Accounts
https://ablenow.com

JOIN: The RealTalk MS Facebook Group
https://facebook.com/groups/realtalkms

REVIEW: Give RealTalk MS a rating and review
http://www.realtalkms.com/review

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 440
Guests: Dr. William Conte

Privacy Policy

Avsnitt(502)

Episode 413: How AI Will Impact MS Patient Care with Dr. Brad Willingham

Episode 413: How AI Will Impact MS Patient Care with Dr. Brad Willingham

We're witnessing the early stages of a paradigm shift, as artificial intelligence is beginning to impact virtually every aspect of healthcare, from research to patient care. And there's much, much mor...

28 Juli 202534min

Episode 412: Understanding Late-Onset MS with Dr. Jacqueline Nicholas

Episode 412: Understanding Late-Onset MS with Dr. Jacqueline Nicholas

More people over the age of 50 are being diagnosed with MS than ever before. When you consider the other health conditions that often develop as we age, and you add the fact that our immune system cha...

21 Juli 202530min

Episode 411: An Encouraging Clinical Trial for Progressive MS with Jason Tardio

Episode 411: An Encouraging Clinical Trial for Progressive MS with Jason Tardio

Back in Episode #401, we reported promising results from a Phase 2 clinical trial for vidofludimus calcium and its impact on progressive MS. This therapy is being developed by Immunic Therapeutics, an...

14 Juli 202531min

Episode 410: From the International Progressive MS Alliance Digital Tools Workshop -- Part Two

Episode 410: From the International Progressive MS Alliance Digital Tools Workshop -- Part Two

Over the past few months, we've shared news about an algorithm that can accurately predict whether someone living with MS will experience worsening symptoms or a relapse in the weeks ahead. You've hea...

7 Juli 202544min

Episode 409: From the International Progressive MS Alliance Digital Tools Workshop

Episode 409: From the International Progressive MS Alliance Digital Tools Workshop

Last week, I was in Philadelphia, attending the Digital Tools Workshop hosted by the International Progressive MS Alliance. Welcome to Part One of our coverage! As we look around us, it's hard to i...

30 Juni 202539min

Episode 408: Explaining Your MS to All Those Well-Meaning Family Members and Friends Who Get It Wrong with Kris Inman

Episode 408: Explaining Your MS to All Those Well-Meaning Family Members and Friends Who Get It Wrong with Kris Inman

Have you experienced those familiar feelings of frustration when the people closest to you don't seem to get your MS? Do you find yourself explaining and re-explaining things to well-meaning friends, ...

23 Juni 202530min

Episode 407: Overcoming Sleep Issues When You're Living with MS with Dr. Katie Siengsukon

Episode 407: Overcoming Sleep Issues When You're Living with MS with Dr. Katie Siengsukon

Getting a good night's sleep is something that benefits everyone. And if you're someone who's living with MS, it's perhaps even more important. But research suggests that more than half the people liv...

16 Juni 202535min

Episode 406: From the 2025 Consortium of MS Centers Annual Meeting: Part Two with Dr. John DeLuca, Dr. Brian Sandroff, and Kristine Werner Ozug

Episode 406: From the 2025 Consortium of MS Centers Annual Meeting: Part Two with Dr. John DeLuca, Dr. Brian Sandroff, and Kristine Werner Ozug

Welcome to Part Two of our coverage of the Consortium of Multiple Sclerosis Centers annual meeting! In this week's episode, Dr. John DeLuca shares research that has identified an effective behavior...

9 Juni 202532min

Populärt inom Hälsa

somna-med-henrik
rss-bara-en-till-om-missbruk-medberoende-2
inga-beiga-morsor
rss-jossan-nina
alska-oss
rss-vuxna-pa-latsas
not-fanny-anymore
angestpodden
sova-med-dan-horning
rss-viktmedicinpodden
sexnoveller-deluxe
johannes-hansen-podcast
brottarbroder
vinterpasset
giggles-med-wiggles
sa-in-i-sjalen
sag-det-bara
rss-sjalsligt-avkladd
till-sangs
halsoveckan-by-tyngre